No Picture
Trading Ideas

Sprint postpaid subscriber loss lower than expected

Analysts were expecting a net loss of 145,000 subscribers, according to research firm FactSet. Sprint, the fourth largest wireless carrier by subscribers, has been aggressive in its 5G push, offering the faster mobile technology in nine cities and bundling it with media content like Hulu and Amazom.com Inc’s Prime. Net loss attributable to the company was $274 million, or 7 cents per share, in the quarter ended Sept. 30, compared with a net income of $196 million, or 5 cents per share, a year earlier. …read more […]

No Picture
Trading Ideas

Earnings: 3 ‘Strong Buy’ Stocks to Watch Monday

There’s no sense denying the fact that investors are relieved by the results so far in Q3 earnings season. Through the summer there were growing signs of a general slowdown in the global economy, and market watchers had expected Q3 results to come in below par. So far, that hasn’t happened – results are good.To date, 341 S&P 500 companies have released their quarterly performance. While aggregate earnings are down 0.6%, that is more than balanced by 4.9% gain in revenues. Of the companies that have reported so far, 60% beat the revenue forecasts and 74% showed EPS beats. These …read more […]

No Picture
Trading Ideas

UPDATE 1-U.S. FDA approves RedHill's bacterial infection treatment

RedHill Biopharma Ltd’s said on Monday its three-drug combination therapy to treat Helicobacter pylori bacterial infections had been approved by the U.S. Food and Drug Administration. The drug, Talicia, is an oral capsule comprising two antibiotics, amoxicillin and rifabutin, as well as omeprazole, a common treatment for heartburn. The Israel-based company said the drug was designed to address the high resistance of H. pylori bacteria to current clarithromycin-based standard-of-care therapies. …read more […]